OrganiGram Holdings Gross Profit vs. Price To Earning

OGI Stock  USD 1.51  0.01  0.67%   
Based on OrganiGram Holdings' profitability indicators, OrganiGram Holdings may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess OrganiGram Holdings' ability to earn profits and add value for shareholders.
 
Gross Profit  
First Reported
2014-09-30
Previous Quarter
-908 K
Current Value
14 M
Quarterly Volatility
14.1 M
 
Yuan Drop
 
Covid
As of now, OrganiGram Holdings' Days Sales Outstanding is increasing as compared to previous years. The OrganiGram Holdings' current Days Of Sales Outstanding is estimated to increase to 114.70, while Price To Sales Ratio is projected to decrease to 2.86. As of now, OrganiGram Holdings' Change To Netincome is increasing as compared to previous years. The OrganiGram Holdings' current Income Quality is estimated to increase to 2.66, while Operating Income is forecasted to increase to (41.7 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.210.2165
Sufficiently Down
Slightly volatile
For OrganiGram Holdings profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OrganiGram Holdings to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OrganiGram Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OrganiGram Holdings's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OrganiGram Holdings over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.79)
Revenue Per Share
1.835
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.06)
Return On Equity
(0.55)
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

OrganiGram Holdings Price To Earning vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining OrganiGram Holdings's current stock value. Our valuation model uses many indicators to compare OrganiGram Holdings value to that of its competitors to determine the firm's financial worth.
OrganiGram Holdings is regarded third in gross profit category among its peers. It also is regarded third in price to earning category among its peers . As of now, OrganiGram Holdings' Gross Profit is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OrganiGram Holdings' earnings, one of the primary drivers of an investment's value.

OrganiGram Price To Earning vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

OrganiGram Holdings

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
35.07 M
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

OrganiGram Holdings

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
(79.96) X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

OrganiGram Price To Earning Comparison

OrganiGram Holdings is currently under evaluation in price to earning category among its peers.

OrganiGram Holdings Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in OrganiGram Holdings, profitability is also one of the essential criteria for including it into their portfolios because, without profit, OrganiGram Holdings will eventually generate negative long term returns. The profitability progress is the general direction of OrganiGram Holdings' change in net profit over the period of time. It can combine multiple indicators of OrganiGram Holdings, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income38.2 M40.1 M
Operating Income-43.9 M-41.7 M
Income Before Tax-209.7 M-199.2 M
Net Loss-206.5 M-196.2 M
Income Tax ExpenseM4.2 M
Total Other Income Expense Net-165.8 M-157.5 M
Net Loss-12.9 M-13.5 M
Net Loss-206.5 M-196.2 M
Net Interest Income-386.1 K-405.4 K
Interest Income11.8 M12.4 M
Change To Netincome200.8 M210.8 M
Net Loss(0.18)(0.19)
Income Quality 2.54  2.66 
Net Income Per E B T 0.99  1.16 

OrganiGram Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on OrganiGram Holdings. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OrganiGram Holdings position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OrganiGram Holdings' important profitability drivers and their relationship over time.

Use OrganiGram Holdings in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OrganiGram Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will appreciate offsetting losses from the drop in the long position's value.

OrganiGram Holdings Pair Trading

OrganiGram Holdings Pair Trading Analysis

The ability to find closely correlated positions to OrganiGram Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OrganiGram Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OrganiGram Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OrganiGram Holdings to buy it.
The correlation of OrganiGram Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OrganiGram Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OrganiGram Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OrganiGram Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your OrganiGram Holdings position

In addition to having OrganiGram Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Munis Funds Thematic Idea Now

Munis Funds
Munis Funds Theme
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:
Check out Your Equity Center.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
To fully project OrganiGram Holdings' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of OrganiGram Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include OrganiGram Holdings' income statement, its balance sheet, and the statement of cash flows.
Potential OrganiGram Holdings investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although OrganiGram Holdings investors may work on each financial statement separately, they are all related. The changes in OrganiGram Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on OrganiGram Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.